SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1288)7/20/1998 6:45:00 PM
From: Steve Harmon  Read Replies (1) of 2742
 
Richard,

I understand your concerns on the science based fundamentals. Galton has dropped the ball several times there.

I have of course been concentrating on the finance fundamentals. The way the financial consultant terms were set up with Bluestone was terrible for the shareholder. Bluestone of course does not want the price of Cistron's stock to go higher until they get the strike price on the other 400,000 warrants. Therefore no stock support has been given to CIST's price in almost a year.

Of course with $12.6 million in cash a small open market buyback could give our shares much needed support also.

If Bruce G. would have been wiser in the above two areas the value of our shares would be 3-4 times higher than where we currently are trading minimum.

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News